From CBC News.

The World Health Organization is backing GLP-1 medications for the treatment of obesity, which some advocates hope will open up access to the drugs and improve affordability. Brands such as Ozempic and Wegovy are already wildly popular in North America.

»»» Subscribe to CBC News to watch more videos: http://bit.ly/1RreYWS

For breaking news, video, audio and in-depth coverage: https://www.cbc.ca/news
Follow CBC News on TikTok: https://www.tiktok.com/@cbcnews
Subscribe to CBC News on Snapchat: https://bit.ly/3leaWsr

Download the CBC News app for iOS: http://apple.co/25mpsUz
Download the CBC News app for Android: http://bit.ly/1XxuozZ

»»»»»»»»»»»»»»»»»»
For more than 80 years, CBC News has been the source Canadians turn to, to keep them informed about their communities, their country and their world. Through regional and national programming on multiple platforms, including CBC Television, CBC News Network, CBC Radio, CBCNews.ca, mobile and on-demand, CBC News and its internationally recognized team of award-winning journalists deliver the breaking stories, the issues, the analyses and the personalities that matter to Canadians.